Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
William Pao, Vincent A Miller, Katerina A Politi et al. · PLoS Medicine · 2005 · Case report
Full textCC BY
Pulmonary and Respiratory Medicine
Filters2 filters applied
1 paperQuestions on this topic